- XIE Y, Choi T, Al-Aly Z
Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.
Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00217.
PubMed Abstract available
Summary for Patients: Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone.
Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00217.
PubMed- COZZOLINO A
Covid-19 vaccine study pulled by US CDC is finally published.
BMJ. 2026;394:e100157.
PubMed - RAN J, Zhu L, Ning M, Zhang W, et al
Age-associated impairment of humoral and cellular immune responses to SARS-CoV-2 in a large community cohort with hybrid immunity.
J Infect. 2026 Jul 1:106803. doi: 10.1016/j.jinf.2026.106803.
PubMed Abstract available - WIDANAGAMAACHCHI WN, Callahan AR, Willson TM, Barbeau B, et al
How Many Veteran COVID-19 Cases Were There during the Pandemic?
J Med Virol. 2026;98:e71040.
PubMed Abstract available - KASSIANOS G, Goodyer L, Gomensoro EEB, Doobaree U, et al
Assessment of the healthcare burden of dengue disease in England: a retrospective analysis (2010-2023).
J Travel Med. 2026 Jul 2:taag059. doi: 10.1093.
PubMed Abstract available - ZHOU X, Ivanov KI, Ge X, Guo X, et al
Identification of GRP78 as a novel host factor that facilitates zoonotic porcine deltacoronavirus internalization and replication via clathrin-mediated endocytosis.
J Virol. 2026 Jul 2:e0071726. doi: 10.1128/jvi.00717.
PubMed Abstract available - TIWAREKAR V, Ebenig A, Predota Y, Schrauf S, et al
Minor differences in the untranslated regions of measles vector additional transcription units are reflected by differential immunogenicity of encoded MERS-CoV Spike antigen.
J Virol. 2026 Jul 1:e0064426. doi: 10.1128/jvi.00644.
PubMed Abstract available - ZHANG L, Li Y, Zhao J, Liang R, et al
Characterization of nucleolar localization signals in the avian infectious bronchitis virus nucleocapsid protein and their critical role in viral replication.
J Virol. 2026;100:e0043326.
PubMed Abstract available - LEUNG PB, Davis AM, Marks KM
Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection.
JAMA. 2026 Jun 30. doi: 10.1001/jama.2026.6918.
PubMed - BLAKNEY AK, Top KA, Cowling BJ, Larson HJ, et al
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.
Lancet. 2026 Jun 30:S0140-6736(26)00512-X. doi: 10.1016/S0140-6736(26)00512.
PubMed Abstract available
Ann Intern Med

No comments:
Post a Comment